Sildenafil ameliorates effects of inhaled nitric oxide withdrawal

Anesthesiology. 1999 Jul;91(1):307-10. doi: 10.1097/00000542-199907000-00041.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 3',5'-Cyclic-GMP Phosphodiesterases / antagonists & inhibitors*
  • Administration, Inhalation
  • Cyclic GMP / metabolism
  • Female
  • Humans
  • Hypertension, Pulmonary / chemically induced
  • Infant
  • Infant, Newborn
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / adverse effects*
  • Phosphodiesterase Inhibitors / pharmacology*
  • Piperazines / pharmacology*
  • Purines
  • Sildenafil Citrate
  • Substance Withdrawal Syndrome / prevention & control*
  • Sulfones

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Nitric Oxide
  • Sildenafil Citrate
  • 3',5'-Cyclic-GMP Phosphodiesterases
  • Cyclic GMP